×
Detection-based prioritisation: Framework of multi-laboratory characteristics for asymp...
https://doi.org/10.1016/j.artmed.2020.101983
Artificial Intelligence in Medicine; Albahri AS, Hamid RA et. al.

Jan 19th, 2021 - Corona virus (COVID) has rapidly gained a foothold and caused a global pandemic. Particularists try their best to tackle this global crisis. New challenges outlined from various medical perspectives may require a novel design solution. Asymptomatic COVID-19 carriers show different health conditions and no symptoms; hence, a differentiation process is required to avert the risk of chronic virus ...

Parasites and Parasitology in this SARS-CoV-2, COVID-19 World: An American Society of P...
https://doi.org/10.1645/20-158
The Journal of Parasitology; Hillyer JF

Jan 15th, 2021 - The novel coronavirus disease 2019 (COVID-19) is one of the worst global health crises of this generation. The core of this pandemic is the rapid transmissibility of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, its high morbidity and mortality, and the presence of infectious asymptomatic carriers. As a result, COVID-19 has dominated this year's headlines and commanded...

Challenge of post-COVID era: management of cardiovascular complications in asymptomatic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797272
Heart Failure Reviews; Gupta S, Mitra A

Jan 11th, 2021 - Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), a highly pathogenic member of family coronaviridae, has caused an exponentially growing global pandemic termed as the coronavirus disease 2019 (COVID-19) with more than 12 million cases worldwide till date. This deadly disease has average fatality rate of 6.5% and even higher among elderly patients and patients with comorbidities. SA...

Seroprevalence and asymptomatic carrier status of SARS-CoV-2 in Wuhan City and other pl...
https://doi.org/10.1371/journal.pntd.0008975
PLoS Neglected Tropical Diseases; Duan S, Zhou M et. al.

Jan 7th, 2021 - Wuhan City (WH) in China was the first place to report COVID-19 in the world and the outbreak of COVID-19 was controlled in March of 2020 in WH. It is unclear what percentage of people were infected with SARS-CoV-2 and what percentage of population is carriers of SARS-CoV-2 in WH. We retrospectively analyzed the SARS-CoV-2 IgG and IgM antibody positive rates in 63,107 healthy individuals from W...

Chinese City of 11 Million Stops People Leaving in Bid to Contain COVID
https://www.medscape.com/viewarticle/943713

Jan 7th, 2021 - SHANGHAI (Reuters) - The capital and largest city in northern China's Hebei province barred people from leaving on Thursday in an effort to curb the spread of the coronavirus as the country reported the biggest rise in daily infections in more than five months. Hebei accounted for 51 of the 52 local cases reported by the National Health Commission on Thursday. This compared with 20 cases report...

The role of serum specific- SARS-CoV-2 antibody in COVID-19 patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759121
International Immunopharmacology; Chen H, Zhang X et. al.

Jan 5th, 2021 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for coronavirus disease 2019 (COVID-19), has rapidly spread, resulting in considerable casualties and serious economic loss worldwide. Disease severity and related symptoms markedly vary among individuals. A large number of patients present atypical symptoms, which represent a big challenge for early diagnosis and prompt ...

Informed sequential pooling approach to detect SARS-CoV-2 infection.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773195
PloS One; Millioni R, Mortarino C

Dec 30th, 2020 - The alarming spread of the pandemic coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus requires several measures to reduce the risk of contagion. Every successful strategy in controlling the SARS-CoV-2 infection depends on timely diagnosis, which should include testing of asymptomatic carriers. Consequently, increasing the throughput for clinical laboratories for the purposes of...

Interrelations between COVID-19 and other disorders.
https://doi.org/10.1016/j.clim.2020.108651
Clinical Immunology (Orlando, Fla.); Gasmi A, Peana M et. al.

Dec 17th, 2020 - The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in December 2019 and has spread across the globe to-date. The disease ranges from asymptomatic carriers to symptoms such as fever, sore throat, cough, lung infections, and in severe cases, acute respiratory distress syndr...

Asymptomatic patients as a source of transmission of COVID-19 in homeless shelters.
https://doi.org/10.1016/j.ijid.2020.12.031
International Journal of Infectious Diseases : IJID : Off... Ralli M, Morrone A et. al.

Dec 15th, 2020 - Asymptomatic carriers account for over a third of all Coronavirus Disease 19 (COVID-19) cases and are characterized by the absence of symptoms but the same infectivity as symptomatic infections. The high percentage of asymptomatic COVID-19 patients is significant in settings with specific vulnerabilities, such as homeless shelters, where the consequences of an outbreak may be dramatic. In this ...

Sexual Health Implications of COVID-19 Pandemic.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643626
Sexual Medicine Reviews; Pennanen-Iire C, Prereira-Lourenço M et. al.

Dec 14th, 2020 - A novel coronavirus (COVID-19) reached pandemic levels by March 11th, 2020, with a destructive impact across socioeconomic domains and all facets of global health, but little is known of its impact on sexual health. To review current knowledge on sexual health-related containment measures during pandemics, specifically COVID-19, and focus on 2 main areas: intimacy and relational dynamics and cl...

Epidemiological characterisation of asymptomatic carriers of COVID-19 in Colombia: a cr...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722836
BMJ Open; Teherán AA, Camero Ramos G et. al.

Dec 9th, 2020 - Asymptomatic carriers (AC) of the new SARS-CoV-2 represent an important source of spread for COVID-19. Early diagnosis of these cases is a powerful tool to control the pandemic. Our objective was to characterise patients with AC status and identify associated sociodemographic factors. Using a cross-sectional design and the national database of daily occurrence of COVID-19, we characterised both...

Molecular epidemiology of SARS-CoV-2 clusters caused by asymptomatic cases in Anhui Pro...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719853
BMC Infectious Diseases; Yuan Y, He J et. al.

Dec 8th, 2020 - COVID-19 is a newly emerging disease caused by a novel coronavirus (SARS-CoV-2), which spread globally in early 2020. Asymptomatic carriers of the virus contribute to the propagation of this disease, and the existence of asymptomatic infection has caused widespread fear and concern in the control of this pandemic. In this study, we investigated the origin and transmission route of SARS-CoV-2 in...

Angiotensin-Converting Enzyme 2 and COVID-19: Patients, Comorbidities, and Therapies.
https://doi.org/10.1152/ajplung.00259.2020
American Journal of Physiology. Lung Cellular and Molecul... Pathangey G, Fadadu PP et. al.

Nov 25th, 2020 - On March 11, 2020, the World Health Organization declared COVID-19 a pandemic, and the reality of the situation has finally caught up to the widespread reach of the disease. The presentation of the disease is highly variable, ranging from asymptomatic carriers to critical COVID-19. The availability of angiotensin-converting enzyme 2 (ACE2) receptors may reportedly increase the susceptibility an...

An overview on COVID-19 pandemic: from discovery to treatment.
https://doi.org/10.2174/1871526520666201109115820
Infectious Disorders Drug Targets; Panati K, Tatireddygari VRA et. al.

Nov 10th, 2020 - Recently, novel coronavirus infection (COVID-19) emerged in Wuhan, China has been declared as pandemic by WHO. Until now, no evidence is documented regarding its wild animal reservoir or intermediary host, but, human-to-human transmission, asymptomatic carriers were very much observed. The number of confirmed cases and death toll have been increased almost all over the world indicating its pote...

Type A Aortic Dissection During COVID-19 Pandemic: Report From Tertiary Aortic Centers ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648657
Seminars in Thoracic and Cardiovascular Surgery; Fukuhara S, Tang H et. al.

Nov 10th, 2020 - Coronavirus disease 2019 (COVID-19) has substantially disrupted many processes of care related to emergency cardiac conditions, while there has been no clinical guidance regarding the management of type A aortic dissection. A retrospective multicenter study involving 52 consecutive patients (mean age 52.3, 28.9% women) with type A aortic dissection during COVID-19 pandemic was conducted at tert...

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts:...
https://doi.org/10.1016/S1473-3099(20)30833-1
The Lancet. Infectious Diseases; Ng OT, Marimuthu K et. al.

Nov 5th, 2020 - The proportion of asymptomatic carriers and transmission risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among household and non-household contacts remains unclear. In Singapore, extensive contact tracing by the Ministry of Health for every diagnosed COVID-19 case, and legally enforced quarantine and intensive health surveillance of close contacts provided a rare op...

Identification of a metabolic, transcriptomic and molecular signature of PNPLA3-mediate...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641518
Hepatology (Baltimore, Md.); Banini BA, P Kumar D et. al.

Nov 1st, 2020 - The global coronavirus disease 2019 (COVID-19) pandemic has posed great challenges in people's daily lives. Highly sensitive laboratory techniques played a critical role in clinical COVID-19 diagnosis and management. In this study the feasibility of using a new digital PCR-based detection assay for clinical COVID-19 diagnosis was investigated by comparing its performance with that of RT-PCR. Cl...

About 17% of COVID-19 Survivors Retest Positive in Follow-Up Study
https://www.medscape.com/viewarticle/940114

Oct 29th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. For reasons unknown, about 1-in-6 people who recovered from COVID-19 subsequently retested positive at least 2 weeks later, researchers reported in a study in Italy. People returned for follow-up visits a mean 17 days after the second negative swab test. Asymptomatic COVID-19 Carriers? "These findings indicate...

Clinical features and antibody response of patients from a COVID-19 treatment hospital ...
https://doi.org/10.1002/jmv.26617
Journal of Medical Virology; Chen Y, Ke Y et. al.

Oct 21st, 2020 - Coronavirus disease 2019 (COVID-19) has rapidly evolved into a global pandemic. A total of 1578 patients admitted into a newly built hospital specialized for COVID-19 treatment in Wuhan, China, were enrolled. Clinical features and the levels of SARS-CoV-2 IgM and IgG were analyzed. In total, 1532 patients (97.2%) were identified as laboratory-confirmed cases. Seventy-seven patients were identif...

Cytosorb filter: An adjunct for survival in the COVID-19 patient in cytokine storm? a c...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500900
Heart & Lung : the Journal of Critical Care; Rizvi S, Danic M et. al.

Oct 12th, 2020 - COVID-19 is a pandemic that has affected not only the United States, but the entire world. The impact it has had has overwhelmed the entire healthcare system, from the unknown carrier status, poor testing capabilities to hospitals running out of ventilators for severely ill patients. There has been a variety of potential treatment modalities for the various forms of illness ranging from asympto...